RxDoctor Payments Data

Mark Malinowski, DO

Interventional Pain Medicine · Chillicothe, OHNPI 1457575961

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Si-bone, Inc. at 39.1% of the total. Reporting peaked in 2019 at $21,023 and has fallen 94.1% since, to $1,247 in 2025.

$39,295in general payments, 2019–2025

Across 291 payments — averaging $135.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$15K
  • Abbott$8K
  • Nalu Medical, Inc.$7K
  • Medtronic$4K
  • Nevro Corp.$1K
  • Vertos Medical, Inc.$723
  • plus $3K from 16 others
$17,662in research payments, 2019–2025

Across 18 payments — averaging $981.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$18K

What the payments were for

  • Consulting fees$21,40754%
  • Travel & lodging$5,86615%
  • Food & beverage$12,02331%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,295 in reported general payments places this provider in the 85th percentile of 67 interventional pain medicine providers in Ohio.

See all interventional pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$125,976
Medicare patients
333
Services billed
1,145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib135$4,216
Pregabalin124$3,960
Gabapentin259$2,572
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen94$2,033
Diclofenac Sodium46$1,700
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen119$1,516
Lidocaine18$1,462
Naloxone Hcl21$1,028
Baclofen28$833
Tramadol Hcl170$769
Tizanidine Hcl156$624
Amitriptyline Hcl36$160
Oxycodone Hcl24$158
Duloxetine Hcl20$154
Methocarbamol16$132

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Chillicothe

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →